Cite
HARVARD Citation
Leleu, X. et al. (2021). A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weekly. Expert review of hematology. 14 (12), pp. 1049-1058. [Online].